I don't think survival data was a part of this announcement. I hope that all 14 patients are still alive, but there's nothing to suggest it. If all the first and second cohort patients were still alive, it would have made for one hell of an announcement and I doubt they would have passed it up at the conference. The first patient was dosed late August 2017(september?). If they were still alive, that would be worth shouting about.
Cheers
Ann: IMU Meets Endpoints in Phase 1b Gastric Cancer Trial, page-12
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
